<code id='99508D6BAD'></code><style id='99508D6BAD'></style>
    • <acronym id='99508D6BAD'></acronym>
      <center id='99508D6BAD'><center id='99508D6BAD'><tfoot id='99508D6BAD'></tfoot></center><abbr id='99508D6BAD'><dir id='99508D6BAD'><tfoot id='99508D6BAD'></tfoot><noframes id='99508D6BAD'>

    • <optgroup id='99508D6BAD'><strike id='99508D6BAD'><sup id='99508D6BAD'></sup></strike><code id='99508D6BAD'></code></optgroup>
        1. <b id='99508D6BAD'><label id='99508D6BAD'><select id='99508D6BAD'><dt id='99508D6BAD'><span id='99508D6BAD'></span></dt></select></label></b><u id='99508D6BAD'></u>
          <i id='99508D6BAD'><strike id='99508D6BAD'><tt id='99508D6BAD'><pre id='99508D6BAD'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:965
          dose of methadone
          A dose of methadone Kevin D. Liles/AP

          The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

          To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges. 

          advertisement

          The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial
          Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCJapanesedrugmakerNipponShinyakusaidon

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Study on Amgen’s bispecific immunotherapy produces positive data

          TheAmgenboothatESMOinMadrid.AndrewJoseph/STATMADRID—AnoveltypeofimmunotherapyfromAmgengeneratedstron